Description

5-AMINO-1MQ (50mg)

5-Amino-1MQ is an experimental small-molecule compound developed for its ability to inhibit the enzyme NNMT (nicotinamide N-methyltransferase). NNMT plays an important role in how the body regulates energy metabolism, fat storage, and cellular methylation balance. Because of this, 5-Amino-1MQ has attracted interest in metabolic research, obesity science, and longevity biology.

Click to access Protocols-3.pdf

NNMT is highly active in white adipose (fat) tissue, particularly in states of obesity and metabolic dysfunction. When NNMT activity is elevated, it diverts nicotinamide away from the NAD⁺ salvage pathway and consumes methyl donors such as SAM (S-adenosylmethionine). This can influence cellular energy production, mitochondrial function, and epigenetic signalling.

By inhibiting NNMT, 5-Amino-1MQ is thought to:

• Increase availability of nicotinamide for NAD⁺ recycling

• Improve mitochondrial efficiency

• Raise cellular energy expenditure

• Reduce fat accumulation in adipose tissue

In preclinical animal studies (primarily in mice), NNMT inhibition with 5-Amino-1MQ has been associated with reduced fat mass, improved insulin sensitivity, and enhanced metabolic activity without necessarily reducing food intake. These findings suggest its effects may stem from improved metabolic efficiency rather than appetite suppression.

In summary, 5-Amino-1MQ is a laboratory-studied NNMT inhibitor with promising metabolic effects in animal models. It represents an emerging area of research at the intersection of fat metabolism, NAD⁺ biology, and epigenetic regulation, but it is not an approved medication and should be considered experimental.